The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC nbcnews.com Submitted by shiruken t3_10lcgah on January 25, 2023 at 10:58 PM in science 75 comments 337
[deleted] t1_j5xhy4v wrote on January 26, 2023 at 6:04 AM Reply to comment by Sufficient-Ad6 in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken [removed] Permalink Parent −1−
Viewing a single comment thread. View all comments